BRIEF

on CannaPharmaRx (NASDAQ:CPMD)

CannaPharmaRX Advances with Alberta Facility and International Expansion

CannaPharmaRX is progressing with its Alberta cannabis facility. Operating four growing rooms, the company plans to add another, targeting a bi-weekly harvest. This setup is estimated to yield 210 kilograms of flowers and 77 kilograms of trim monthly.

Current non-branded products are priced between 1.9 and 2.2 CAD per gram for flowers. Revenue projections estimate 430,000 CAD monthly. By late 2025, CannaPharmaRX aims to launch branded products with prices up to 3 CAD per gram.

Internationally, shipments to Israel begin in December 2024. Additionally, partnerships enable further sales with a commission model. A study aiming at European markets, notably Germany, is underway.

Future plans include adding a drying room for enhanced production and introducing branded products. The company seeks a CEO for global growth while addressing regulatory challenges in Canada.

R. P.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all CannaPharmaRx news